Cystic fibrosis and respiratory illnesses

There is still no cure for cystic fibrosis, and with a child born every four days in Australia with the chronic respiratory illness, it is important to keep funding research in this area.

With the support of donations, research so far has contributed to the development of new therapies and treatments for children with cystic fibrosis, which has resulted in improved health outcomes, better quality of life and longer life expectancy for children.

Research currently funded aims to develop and implement new diagnostic tests that can quickly detect the presence of a bug known to cause serious respiratory infections in children with cystic fibrosis, as well as to predict resistance to key antibiotics used to treat the infection.

Other research into respiratory illness is changing treatment methods for infants who are diagnosed with bronchiolitis – the most common reason worldwide for infants under 12 months of age to be admitted to hospital.

A current clinical trial is investigating the optimal duration of antibiotics required to treat chronic wet cough in children, and prevent it coming back. The results of this world-first clinical trial will be incorporated in national and international clinical practice guidelines.